Thèse de doctorat

  1. Microfluidic platforms for the validation of new targeted therapies for personalised medicine against osteosarcoma 2018

    Universidad de Navarra

Jurys de thèses (1)

  1. Rapporteur du jury

    Synergistic effect of novel HDAC inhibitors with chemotherapy drugs in acute myeloid leukemia 2022

    Universidad de Navarra

    Gimenez Camino, Naroa